Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study.
作者信息
Birabaharan Morgan, Kaelber David C, Karris Maile Y
机构信息
Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California.
Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio; Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio.
出版信息
J Am Acad Dermatol. 2022 Sep;87(3):649-651. doi: 10.1016/j.jaad.2021.11.025. Epub 2021 Nov 23.
Abstract
摘要
相似文献
1
Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study.信使核糖核酸新冠疫苗接种后带状疱疹再激活的风险：一项队列研究。
J Am Acad Dermatol. 2022 Sep;87(3):649-651. doi: 10.1016/j.jaad.2021.11.025. Epub 2021 Nov 23.
2
Correspondence on 'Herpes Zoster and Simplex reactivation following COVID-19 vaccination'.关于“新冠病毒疫苗接种后带状疱疹和单纯疱疹再激活”的通信
Expert Rev Vaccines. 2022 Aug;21(8):1159. doi: 10.1080/14760584.2022.2070155. Epub 2022 Apr 29.
3
Reply to: correspondence on "Herpes Zoster and Simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis".回复：关于“COVID-19疫苗接种后带状疱疹和单纯疱疹再激活：来自疫苗不良事件报告系统（VAERS）数据库分析的新见解”的通信
Expert Rev Vaccines. 2022 Aug;21(8):1161-1162. doi: 10.1080/14760584.2022.2070961. Epub 2022 May 17.
4
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.mRNA 和腺病毒载体 COVID-19 疫苗接种后带状疱疹再激活：国家健康保险数据库分析。
J Infect Dis. 2023 Nov 11;228(10):1326-1335. doi: 10.1093/infdis/jiad297.
5
Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273).带状疱疹报告与 mRNA COVID-19 疫苗（BNT162b2 和 mRNA-1273）之间的关联研究。
Br J Clin Pharmacol. 2022 Jul;88(7):3529-3534. doi: 10.1111/bcp.15280. Epub 2022 Feb 28.
6
Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis.2019冠状病毒病疫苗接种与带状疱疹的关联：一项系统评价和荟萃分析
Expert Rev Vaccines. 2022 May;21(5):601-608. doi: 10.1080/14760584.2022.2036128. Epub 2022 Feb 7.
7
Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis.新型冠状病毒肺炎疫苗接种后带状疱疹和单纯疱疹再激活：来自疫苗不良事件报告系统（VAERS）数据库分析的新见解
Expert Rev Vaccines. 2022 May;21(5):675-684. doi: 10.1080/14760584.2022.2044799. Epub 2022 Feb 25.
8
Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis.带状疱疹与新冠病毒疫苗接种的关联：一项系统评价与荟萃分析。
J Am Acad Dermatol. 2023 Aug;89(2):370-371. doi: 10.1016/j.jaad.2023.03.031. Epub 2023 Mar 30.
9
Risk of herpes zoster following mRNA COVID-19 vaccine administration.mRNA COVID-19 疫苗接种后的带状疱疹风险。
Expert Rev Vaccines. 2023 Jan-Dec;22(1):643-649. doi: 10.1080/14760584.2023.2232451.
10
Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.评估 COVID-19 疫苗接种者中带状疱疹的风险。
JAMA Netw Open. 2022 Nov 1;5(11):e2242240. doi: 10.1001/jamanetworkopen.2022.42240.
引用本文的文献
1
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review.2019年冠状病毒病大流行对带状疱疹发病率的影响：一项叙述性文献综述
Infect Dis Ther. 2024 Mar;13(3):447-461. doi: 10.1007/s40121-024-00924-3. Epub 2024 Mar 5.
2
Herpes Zoster after COVID-19 Infection or Vaccination: A Prospective Cohort Study in a Tertiary Dermatology Clinic.新型冠状病毒感染或接种疫苗后发生的带状疱疹：一项在三级皮肤科诊所开展的前瞻性队列研究
Dermatol Res Pract. 2023 Dec 31;2023:2206498. doi: 10.1155/2023/2206498. eCollection 2023.
3
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.带状疱疹与新冠病毒疫苗接种：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2023 Nov 16;16:3323-3331. doi: 10.2147/CCID.S441898. eCollection 2023.
4
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus.疫苗接种在 COPD 中的作用：流感、SARS-CoV-2、肺炎球菌、百日咳、呼吸道合胞病毒和水痘带状疱疹病毒。
Eur Respir Rev. 2023 Sep 6;32(169). doi: 10.1183/16000617.0034-2023. Print 2023 Sep 30.
5
Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.新冠病毒疫苗接种后疱疹病毒再激活：系统评价和荟萃分析。
Eur J Med Res. 2023 Aug 10;28(1):278. doi: 10.1186/s40001-023-01238-9.
6
Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand.新西兰接种 BNT162b2 mRNA COVID-19 疫苗（辉瑞-生物科技）后的不良事件。
Drug Saf. 2023 Sep;46(9):867-879. doi: 10.1007/s40264-023-01332-1. Epub 2023 Aug 9.
7
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.mRNA 和腺病毒载体 COVID-19 疫苗接种后带状疱疹再激活：国家健康保险数据库分析。
J Infect Dis. 2023 Nov 11;228(10):1326-1335. doi: 10.1093/infdis/jiad297.
8
Risk of Herpes Zoster Ophthalmicus After COVID-19 Vaccination in a Large US Health Care Claims Database.美国大型医疗保健索赔数据库中 COVID-19 疫苗接种后带状疱疹性眼病的风险。
Am J Ophthalmol. 2024 Feb;258:139-144. doi: 10.1016/j.ajo.2023.07.004. Epub 2023 Jul 7.
9
Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study.基于多地区人群的队列研究，用于评估带状疱疹与严重急性呼吸综合征冠状病毒2的mRNA疫苗接种之间的关联：金星研究。
Open Forum Infect Dis. 2023 May 18;10(7):ofad274. doi: 10.1093/ofid/ofad274. eCollection 2023 Jul.
10
Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.评估 COVID-19 疫苗接种者中带状疱疹的风险。
JAMA Netw Open. 2022 Nov 1;5(11):e2242240. doi: 10.1001/jamanetworkopen.2022.42240.
Zotero 插件